Proteins suggest a path to reduce drug resistance in a form of cancer
Doctors have nearly a dozen new targeted drugs to treat patients with acute myeloid leukemia, or AML, yet three of four patients still die within five years. Some patients succumb within just a month or two, despite the battery ...
Feb 2, 2024
0
38